Torus Biosystems

📍 Medford, United States🗓 Founded 2019👥 26 employees
Biotechnology Research🌐 torus.bio
Website LinkedIn
Torus Biosystems was spun out from the Wyss Institute for Biologically Inspired Engineering at Harvard University in 2020 to develop and commercialize the proprietary DNA/RNA detection technology developed by Wyss Core Faculty member, Peng Yin, PhD, Professor, Department of Systems Biology, Harvard Medical School, and Wyss Alumnus David Zhang, PhD, Associate Professor of Bioengineering, Rice University. Learn more about how Torus Bio can help improve patient outcomes, combat antibiotic resistance, and promote antimicrobial stewardship in a wide range of ambulatory settings including Hospital Outpatient and Emergency Departments and Long-Term Care facilities. Visit the website at www.torus.bio and connect with on social media @Twitter and @LinkedIn.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Torus Biosystems founded?
Torus Biosystems was founded in 2019.
What industry is Torus Biosystems in?
Torus Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Torus Biosystems based?
Torus Biosystems is headquartered in Medford, United States.